Finzati - Logo
HRMY logo

Harmony Biosciences Holdings, Inc.

HRMY • Biotechnology
$42.25
▲ +0.39 (+0.93%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$2.48B
Growth
—
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 18.3%Positive revenue growth · 29.9%Positive free cash flow · 6.05Consistent free cash flow · 5/5Reasonable earnings multiple · 13.56
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:53 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$42.25
Change0.93%
Shares Out58.77M
Market Cap$2.48B
Enterprise Value$1.97B
52W Range25.52 - 40.87
Beta0.94
P/E13.70
P/S2.59
P/B2.48
P/FCF7.40
EV/Sales2.05

Investment DNA

How strong this company looks for long-term investors

92
out of 100
Business Quality
Margins, moat, returns
89/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
87/100
Why this score▼
Stable or improving margins · 18.3%Positive revenue growth · 29.9%Positive free cash flow · 6.05Consistent free cash flow · 5/5Reasonable earnings multiple · 13.56Manageable debt level · 0.28

Analyst view

Analyst sentiment and price target

HRMY
Analyst sentiment
Based on 13 analyst votes · 2026-09-05
73/100
Bullish
Bullish
8
Hold
3
Bearish
2
Price Target
2026-08-06
Low
$34.00
Mean
$46.20
Median
$39.00
High
$70.00

Company Overview

IPO: 8/19/2020
Industry: Biotechnology
P/B i: 2.48
Debt / Equity i: 0.28
Operating Margin: 24.00%
Net Margin: 18.27%
ROE i: -
ROIC: -

Financial Health

Score19 / 20
Debt / Equity: 0.28
Current Ratio: 3.60
Quick Ratio: 3.58
Status: Strong

Insider Transactions

Recent executive and insider activity

Mollichella Stephen M.
Transaction: 07/16/2026
OTHER
Change
+5,900
Price
Not reported
Filing
07/22/2026
Type
OTHER
Mollichella Stephen M.
Transaction: 07/16/2026
OTHER
Change
+20,750
Price
$36.76
Filing
07/22/2026
Type
OTHER
Mollichella Stephen M.
Transaction: 07/16/2026
OTHER
Change
0
Price
Not reported
Filing
07/22/2026
Type
OTHER